A B S T R A C T When 70-80-g male albino rats eat a diet furnishing daily requirement of valine for optimal growth (70 iumol/g) and all other nutrients ("complete diet"), they gain weight at an average rate of 3.0 g/100 g body wt/day. When valine is removed, they lose weight at an average 2.1 g/100 g body wt/day. The growth retardation is improved or corrected by adding valine to the diet, daily weight gain being proportional to dietary valine content over a range of 0-70 /%mol/g.
INTRODUCTION
* During , investigations in several laboratories showed a-keto analogues of valine, leucine, isoleucine, phenylalanine, tyrosine, histidine, tryptophan, and methionine can be utilized in place of corresponding essential amino acids to sustain growth of the immature rat (1) (2) (3) (4) (5) (6) (7) . Percent efficiency of the keto derivative as a substitute for the corresponding amino acid in the diet of growing rats can be defined as: 100 X (intake of amino acid required for specified rate of growth)/(intake of keto analogue required to achieve same rate of growth). The studies of 1940-1963 did not establish the efficiency with which each keto analogue substitutes for its related amino acid.
Balance studies in human subjects have confirmed that man, like the rat, can utilize a-ketoisovaleric and phenylpyruvic acids in place of valine and phenylalanine, respectively (8, 9) . Efficiencies of these replacements were shown to be less than 100%, but were not quantified. Subsequently Walser et al. reported that substitution of a-keto acids for corresponding essential amino acids in diet of patients with renal or hepatic insufficiency had beneficial effects of reducing azotemia and hyperammonemia, respectively (10, 11) .
a-Hydroxy acids can also substitute for corresponding amino acids in the rat, as first reported by Rose (12) . Pond, Breuer, Loosli, and Warner (13) examined the utilization of a-hydroxy analogues of isoleucine, lysine, threonine, and tryptophan. A mixture of DL-isomers of hydroxy acids were used in these experiments. Only a partial utilization of the a-hydroxy analogue of isoleucine was observed at one dose level; the hydroxy analogue of threonine was reportedly not utilized. Tryptophan could be replaced with its DL-hydroxy analogues; utilization was thought to be essentially complete. Hy-droxy analogues, if utilizable, may have the same potential application in treatment of azotemia and hyperammonemia as the keto compounds. Which derivative is the preferable substitute for each essential amino acid will depend on ease of laboratory synthesis and efficiency as a substitute for the corresponding amino acid.
The present study, conducted in the growing rat, had these objectives: (a) development of a method for measuring efficiency with which a-ketoisovaleric replaces valine; (b) if conversion is incomplete, the study of possible contributions of gastrointestinal Synthesis of sodium a-ketoisovalerate. This compound was synthesized by a modification of the procedure of Weygand, Steglich, and Tanner (14) . Yield was 36% of theory.
Nuclear magnetic resonance spectrum of the synthetic material (in D20) confirmed its structure as shown below (tetramethylsilane was the external standard):
(a) a doublet at 8.8 r; coupling constant 3.5 Hz, and a peak area corresponding to 6 H of the two methyl groups of CH3 CH-
CH3
(b) a quartet at 6.9 r; coupling constant 3.5 Hz, and a peak area corresponding to Five types of diet were used: (a) "complete" rat diet of Rogers and Harper (18) , which provides daily requirement for optimal growth of all nutrients, including 70 ,umol valine/g; (b) "valine-free" representing complete diet minus valine; (c) valine-free to which varying amounts of valine were added; (d) valine-free containing desired quantities of the sodium salt of a-ketoisovaleric acid; (e) valine-free containing specified amount of Na salt of a-hydroxyisovaleric acid.
Rats were fed complete diet for 3 days before the experiment began. Each experiment lasted 20 days and involved 60-120 animals. During the first 10 days, they continued on complete diet. Then they were divided into groups of 8-12. Each group ate a different diet during the next 7 days, such as complete, valine-free, and and valine-free containing specified amounts of valine or valine derivative. Food intake and weight were measured daily. At conclusion of the experiment, rats weighed 95-150 g, depending on diet.
Decarboxylation studies. This experiment examined three groups of rats (each containing three animals), which were fed "complete" diet, "valine-free" diet, or "valine-free" diet containing 70 ,umol a-ketoisovaleric acid/g. 1-2 ,uCi of sodium [1-`4C]c-ketoisovalerate in 0.5 ml saline, sterilized by filtration through a 0.22-,m Nalge filter (Nalge Co., Nalgene Labware Div., Rochester, N. Y.), was injected intravenously. The rat was placed in the apparatus described by MacKenzie et al. (19) and exhaled CO2 was trapped in a 1 N solution of Hyamine hydroxide in methanol. 1'CO2 content of the Hyamine solution was measured at specified intervals for 24 h by liquid scintillation spectrometry (20) . Urine, collected during the 24-h period, was also examined for radioactivity.
Determination of (14C]valine in the carcass. Rats were injected subcutaneously with 10 ,uCi uniformly labeled sodium a-ketoisovalerate (4 pCi/mmol). homogenized in water to a known volume (35-40 ml) and an aliquot of the suspension (shaken well before withdrawing the sample) was assayed for radioactivity (20) .
To correct for quenching in 'C analyses, internal standards were employed.
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days'geqili-Thus, the bacitracin-polymyxin-neomycin combination dy2 't e ti reduced efficiency of a-ketoisovaleric acid as a subDurin dat s stitute for valine by 25-50% (Fig. 3 (Fig. 2) . Rats eating hydroxy acid showed a daily weight change of + 0.26 g/100 g body wt and daily food intake of 7.9 g/100 g body wt. These responses were similar to those of rats offered 60 imol a-ketoisovaleric acid. DISCUSSION Growth assay of valine. Withdrawal. of valine causes two effects which can be measured in this type of experiment: decline in weight gain and reduction in food intake. Diminished appetite after withdrawal of an essential amino acid is a familiar phenomenon (23) but its mechanism has not been elucidated. Since food intake and weight gain are both dependent on valine content of the diet and are in fact approximately linear functions of each other,1 either variable can serve as "response" component of the assay for dietary content of valine or its metabolic precursor. Because food intake changes at different levels of dietary content of valine or precursor, "dose" component of the assay can also be expressed in two ways: amino (keto-, hydroxy-) acid "offered" or "consumed."
Efficiency of a-ketoisovaleric acid. Efficiency of a-ketoisovaleric acid as a substitute for valine can be expressed, at any selected level of response, as 100 X micromoles valine (offered or consumed)/micromoles keto acid (offered or consumed) required to produce the specified response. The four types of plot lead to similar conclusions ( Fig. 2 and Appendix1): (a) efficiency of the substitution ranges between 30 and 80%; (b) efficiency is inversely related to dietary content, being 80% when diet contains 17.5 ;&mol/g' and 37% when diet provides 140 /Amol/g.' In general agreement, when uniformly labeled a-ketoisovaleric acid was injected in rats offered 70 amol keto acid/g diet, about i was recovered as tissue valine 24 of keto acid along the pathway beginning a-ketoisovaleric acid > isobutyric acid + CO; (d) urinary excretion of keto acid.
The experimental results exclude (a) and (d), and demonstrate a contribution by (c). Two metabolic pathways are available to a-ketoisovaleric acid: (1) valine + a-ketoglutaric acid = a-ketoisovaleric (2) acid + glutamic acid a-ketoisovaleric acid -* isobutyric acid + C02 (3) Reactions 1 and 2 are catalyzed by transaminases present in liver, muscle, and other extrahepatic tissues (23, 24); reaction 3 is performed by branched chain dehydrogenase-decarboxylase located primarily in liver (23) . Theoretically, efficiency of a-ketoisovaleric acid as a substitute for valine will be inversely related to rate of reaction 3 and directly related to rate of reaction 2. When rats eating valine-free diets containing 0, 35, or 70 ,.mol/g diet a-ketoisovaleric acid were injected with 1-2 MCi of the keto acid labeled with "C in the C-1 position, 30-80% of the 14C was exhlaled as CO within 24 h.' Since pool size of the keto acid and degree of equilibration of injected acid with endogenous pool were not determined, these experiments can only be interpreted qualitatively as evidence that a substantial proportion of keto acid followed reaction 3, representing irreversible degradation. Accordingly, a major factor in inefficiency of the keto acid as a substitute for valine appears to be the action of the branched chain decarboxylase-dehydrogenase.
Gastrointestinal flora could be influential in two ways: by transaminating a-ketoisovaleric acid to valine (a reaction known to be accomplished by Escherichia coli [25] ), they could enhance efficiency of the keto acid as a dietary replacement for valine; by decarboxylating the compound (a reaction also catalyzed by E. coli [26] ), they could reduce efficiency. Attempting to distinguish these possibilities, we measured growth responses to valine and its keto acid while intestinal flora was suppressed with antibiotics. Interpretation of the experiments is complicated by the fact that under influence of antibiotics, growth response of rats to valine itself was altered. At each level of valine intake from 0 to 140 Imol/g diet, antibiotic-treated rats grew more rapidly than nontreated animals ( Fig. 4 and Appendix'). The growth-promoting effect of antibiotics in rats fed suboptimal diets has been described before (27) , but the mechanism is unknown. Although antibiotics ameliorated the growth-stunting effect of valine-deficient diet, simultaneously they reduced the efficiency of the keto analogue as a replacement for valine (Fig. 3) . The decrease in efficiency with which the a-keto acid substituted for valine amounted to a 50% loss at intake of 17.5 Amol/g diet8 and 20% loss at 70 Amol/g diet.'
This effect of antibiotics suggests the intestinal flora may accomplish the transamination (reaction 2) of a portion of ingested a-ketoisovaleric acid. Suppression of this activity by antibiotics would reduce efficiency of the keto acid as a dietary substitute for valine. Other explanations are possible, however, such as shift in enteric flora to a species with increased capacity to degrade a-ketoisovaleric acid by reaction 3.
a-Hydraxyisovaleric acid can replace valine in the rat's diet. At the single dose tested (the molar equivalent of the daily requirement of valine), efficiency of utilization was about 45%. Thus, the a-hydroxy and a-keto compounds are comparable as substitutes for valine. a-Hydroxyisovaleric acid, readily synthesized from valine by reaction with nitrous acid (17) , is less costly than. the keto analogue ($0.70 vs. $2.50/g in present syntheses). Conversion of protein hydrolysates to a N-free mixture of hydroxy acids via the nitrous acid reaction could provide unlimited supplies of mixed hydroxy analogues of most amino acids at relatively low cost.
The enzymatic mechanism for converting a-ketoisovaleric acid to valine is known: transamination. Which enzyme(s) convert the a-hydroxy acid is a question for future study. Oxidation to the keto acid by L-a-hydroxy acid oxidase, known to be present in rat kidney, is a possible step (28, 29) .
